HSWM
ABBV icon

Hubbell Strickland Wealth Management’s AbbVie ABBV Stock Holding History

Hubbell Strickland Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
4,682
+6
+0.1% +$1.29K 0.43% 31
2026
Q1 		$1.02M Buy
4,676
+17
+0.4% +$3.77K 0.41% 33
2025
Q4 		$1.06M Sell
4,659
-154
-3% -$35.1K 0.43% 29
2025
Q3 		$1.11M Buy
4,813
+18
+0.4% +$3.67K 0.46% 28
2025
Q2 		$890K Sell
4,795
-47
-1% -$8.73K 0.39% 30
2025
Q1 		$1.01M Sell
4,842
-50
-1% -$9.72K 0.48% 26
2024
Q4 		$869K Buy
4,892
+15
+0.3% +$2.76K 0.41% 28
2024
Q3 		$963K Buy
4,877
+8
+0.2% +$1.49K 0.45% 27
2024
Q2 		$835K Sell
4,869
-27
-0.6% -$4.47K 0.42% 27
2024
Q1 		$892K Buy
4,896
+20
+0.4% +$3.45K 0.45% 27
2023
Q4 		$756K Buy
4,876
+23
+0.5% +$3.35K 0.41% 27
2023
Q3 		$723K Buy
4,853
+21
+0.4% +$3.08K 0.43% 27
2023
Q2 		$651K Buy
4,832
+105
+2% +$15.4K 0.38% 29
2023
Q1 		$753K Sell
4,727
-765
-14% -$117K 0.46% 27
2022
Q4 		$888K Buy
5,492
+117
+2% +$17.9K 0.54% 25
2022
Q3 		$721K Buy
5,375
+27
+0.5% +$3.87K 0.5% 29
2022
Q2 		$819K Buy
5,348
+26
+0.5% +$3.97K 0.55% 26
2022
Q1 		$863K Buy
5,322
+27
+0.5% +$3.92K 0.51% 27
2021
Q4 		$717K Buy
5,295
+4
+0.1% +$473 0.4% 35
2021
Q3 		$571K Buy
5,291
+30
+0.6% +$3.43K 0.35% 37
2021
Q2 		$593K Buy
5,261
+30
+0.6% +$3.38K 0.36% 38
2021
Q1 		$566K Buy
5,231
+32
+0.6% +$3.42K 0.36% 36
2020
Q4 		$557K Buy
5,199
+31
+0.6% +$2.98K 0.38% 36
2020
Q3 		$453K Buy
5,168
+53
+1% +$4.99K 0.35% 42
2020
Q2 		$502K Buy
5,115
+102
+2% +$8.98K 0.42% 34
2020
Q1 		$382K Buy
5,013
+26
+0.5% +$2.21K 0.39% 38
2019
Q4 		$442K Buy
4,987
+29
+0.6% +$2.41K 0.36% 39
2019
Q3 		$375K Buy
+4,958
New +$340K 0.32% 41

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Hubbell Strickland Wealth Management's ABBV Position: Q2 2026 in Review

Hubbell Strickland Wealth Management increased its AbbVie (ABBV) stake by 0.13% in Q2 2026, buying an estimated $1.29K and bringing the position to 4,682 shares worth $1.18M. The position accounts for 0.43% of the portfolio, ranked #31.

Hubbell Strickland Wealth Management first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hubbell Strickland Wealth Management held 4,682 shares of AbbVie worth $1.18M as of Q2 2026.
  • Hubbell Strickland Wealth Management bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.43% of Hubbell Strickland Wealth Management's portfolio in Q2 2026, its #31 holding.
  • Hubbell Strickland Wealth Management first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hubbell Strickland Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.